STOCK TITAN

Assure to Present at the LD Micro Invitational

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Assure Holdings Corp. (NASDAQ: IONM) will present at the LD Micro Invitational on June 8, 2022, at 7:30 p.m. ET. John Farlinger, the executive chairman and CEO, will lead the presentation, which will be webcasted live through the company's investor relations site. Additionally, Assure management will hold one-on-one meetings with investors on June 7-8, 2022. The LD Micro Invitational is a three-day conference featuring around 200 companies, offering half-hour presentations and private meetings. Assure specializes in intraoperative neuromonitoring and remote neurology services.

Positive
  • None.
Negative
  • None.

DENVER, June 02, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that it is scheduled to present at the LD Micro Invitational on June 8, 2022. 

John Farlinger, executive chairman and CEO will present to investors at 7:30 p.m. ET. The investor presentation will be webcast live and is available via the Assure investor relations site. Additionally, Assure management will participate in one-on-one meetings with investors on June 7th-8th, 2022. For additional information, to register, watch the virtual investor presentation or to schedule a meeting with management, please visit: https://ldinv12.mysequire.com/.

The LD Micro Invitational is a three-day, investor conference expected to feature approximately 200 companies presenting in half-hour increments, as well as private meetings.

About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: expectations with respect to the Company’s growth and development and the quality and results of future services. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-617-2526
Scott.Kozak@assureiom.com


FAQ

When is Assure Holdings scheduled to present at the LD Micro Invitational?

Assure Holdings is scheduled to present on June 8, 2022, at 7:30 p.m. ET.

Who will present Assure Holdings at the LD Micro Invitational?

John Farlinger, the executive chairman and CEO, will present Assure Holdings at the event.

How can investors access the Assure Holdings presentation?

Investors can access the Assure Holdings presentation via the company's investor relations website.

What is the LD Micro Invitational?

The LD Micro Invitational is a three-day investor conference featuring approximately 200 companies presenting in half-hour increments.

What dates will Assure management have one-on-one meetings with investors?

Assure management will participate in one-on-one meetings with investors on June 7-8, 2022.

What services does Assure Holdings provide?

Assure Holdings provides intraoperative neuromonitoring and remote neurology services to support surgeries involving the nervous system.

ASSURE HLDGS CORP

OTC:IONM

IONM Rankings

IONM Latest News

IONM Stock Data

365.19k
2.99M
4.46%
32.33%
Medical Care Facilities
Surgical & Medical Instruments & Apparatus
Link
United States of America
GREENWOOD VILLAGE